Prokidney Corp (PROK) Stock Price, Quote & News

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 336 999 7028

Website: prokidney.com

Address:

2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States

BestNwest Aug. 23 at 3:25 AM

$PROK hype to 4$ monday

0 · Reply

Jimmity Aug. 22 at 4:40 PM

$PROK So the Proact 1 readout is suppose to occur in 2027. Anyone know if they will give a interim readout on the Proact 1 study and when that would be ? TY

2 · Reply

BottomFishingCharts Aug. 22 at 3:03 PM

$PROK... Loading... Momentum twitching in #OverSold zone.. #BottomFishing 📉📈

0 · Reply

michaelburryburner Aug. 21 at 2:45 PM

$PROK okay okay that was my last buy I promise 😉 $2.29 nimble

0 · Reply

Asensus2023 Aug. 20 at 4:02 PM

$PROK no Will not happen.

0 · Reply

wavridr Aug. 20 at 2:34 PM

$PROK 1.90 by Friday

0 · Reply

wavridr Aug. 20 at 1:48 PM

$PROK 2.15 target for today

0 · Reply

michaelburryburner Aug. 19 at 6:35 PM

$PROK added again, I own a lot of shares. The falling wedge on the monthly + analyst targets of $5+ make me comfortable to hold. ✌🏼

1 · Reply

wavridr Aug. 19 at 5:11 PM

$PROK erased 3 green days in just half a day 😂

0 · Reply

Senorfrog22 Aug. 19 at 2:39 PM

$PROK

0 · Reply

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Jul 15, 2025, 7:30 AM EDT - 5 weeks ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 9, 2025, 11:22 AM EDT - 6 weeks ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 8:45 AM EDT - 6 weeks ago

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 7:30 AM EDT - 6 weeks ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 8, 2025, 5:09 PM EDT - 6 weeks ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 1:25 PM EDT - 6 weeks ago

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 9:05 AM EDT - 6 weeks ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 7:00 AM EDT - 6 weeks ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 1, 2025, 12:43 PM EDT - 7 weeks ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

May 12, 2025, 4:15 PM EDT - 3 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 5 months ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Jan 31, 2025, 11:08 AM EST - 7 months ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 6:10 AM EST - 7 months ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Nov 26, 2024, 7:30 AM EST - 9 months ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 12, 2024, 7:30 AM EST - 10 months ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 5, 2024, 7:30 AM EST - 10 months ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Oct 14, 2024, 7:30 AM EDT - 11 months ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 9, 2024, 7:30 AM EDT - 11 months ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

Mar 25, 2024, 6:05 AM EDT - 1 year ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 21, 2024, 7:49 PM EDT - 1 year ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Feb 29, 2024, 4:05 PM EST - 1 year ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Nov 30, 2023, 6:05 AM EST - 1 year ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 21, 2023, 6:05 AM EST - 1 year ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 16, 2023, 4:40 PM EST - 1 year ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:05 AM EST - 1 year ago

ProKidney Reports Third Quarter Financial Results

Nov 13, 2023, 5:02 PM EST - 1 year ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Oct 30, 2023, 4:12 PM EDT - 1 year ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Jul 18, 2023, 6:05 AM EDT - 2 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 15, 2023, 2:02 AM EDT - 2 years ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jun 13, 2023, 12:05 PM EDT - 2 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

Jun 1, 2023, 4:05 PM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

May 11, 2023, 4:01 PM EDT - 2 years ago

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 4, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Present at the BofA Securities Health Care Conference 2023

Apr 12, 2023, 11:51 AM EDT - 2 years ago

ProKidney: Too Many Billionaires, Too Little Data

Mar 28, 2023, 4:12 PM EDT - 2 years ago

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

Mar 3, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in TD Cowen's 43rd Annual Health Care Conference

Jan 11, 2023, 7:48 AM EST - 2 years ago

ProKidney's stock jumps 29%

Jan 10, 2023, 4:05 PM EST - 2 years ago

ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease

BestNwest Aug. 23 at 3:25 AM

$PROK hype to 4$ monday

0 · Reply

Jimmity Aug. 22 at 4:40 PM

$PROK So the Proact 1 readout is suppose to occur in 2027. Anyone know if they will give a interim readout on the Proact 1 study and when that would be ? TY

2 · Reply

BottomFishingCharts Aug. 22 at 3:03 PM

$PROK... Loading... Momentum twitching in #OverSold zone.. #BottomFishing 📉📈

0 · Reply

michaelburryburner Aug. 21 at 2:45 PM

$PROK okay okay that was my last buy I promise 😉 $2.29 nimble

0 · Reply

Asensus2023 Aug. 20 at 4:02 PM

$PROK no Will not happen.

0 · Reply

wavridr Aug. 20 at 2:34 PM

$PROK 1.90 by Friday

0 · Reply

wavridr Aug. 20 at 1:48 PM

$PROK 2.15 target for today

0 · Reply

michaelburryburner Aug. 19 at 6:35 PM

$PROK added again, I own a lot of shares. The falling wedge on the monthly + analyst targets of $5+ make me comfortable to hold. ✌🏼

1 · Reply

wavridr Aug. 19 at 5:11 PM

$PROK erased 3 green days in just half a day 😂

0 · Reply

Senorfrog22 Aug. 19 at 2:39 PM

$PROK

0 · Reply

michaelburryburner Aug. 19 at 2:18 PM

$PROK great close yesterday, then low volume sell off classic

0 · Reply

wavridr Aug. 19 at 1:35 PM

$PROK back on track to $1

0 · Reply

michaelburryburner Aug. 19 at 12:26 PM

$PROK lets see $3 💥

0 · Reply

BenGang Aug. 18 at 9:34 PM

$PROK

0 · Reply

SmartWentCrazy Aug. 18 at 7:57 PM

$PROK hedge shares, create big public print to make a nice price, distribute your hedged shares to dark pool participants, distribute the float, get fund back to rebalanced from overweight holdings due to run up, cover, then allow repricing. Easy game they play.

0 · Reply

wavridr Aug. 18 at 7:56 PM

$PROK time for the 1 mil share dump

0 · Reply

RedDogSailor Aug. 18 at 7:49 PM

$PROK me too

0 · Reply

michaelburryburner Aug. 18 at 7:42 PM

$PROK added again here

0 · Reply

BenGang Aug. 18 at 7:42 PM

$GRI $PROK

0 · Reply

SmartWentCrazy Aug. 18 at 7:41 PM

$PROK @wavridr doesn’t even know most trading on this ticker is done in dark pools.

0 · Reply

SmartWentCrazy Aug. 18 at 6:16 PM

$PROK lol. @wavridr blocked me! Clearly so he can continue his misinformation campaign unchecked.

0 · Reply

Market Cap	705.40M
Revenue (ttm)	80,000.00
Net Income (ttm)	-61.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-76,487.50%
Debt to Equity Ratio	0.00

Volume	1,580,100
Avg Vol	16,650,846
Day's Range	N/A - N/A
Shares Out	292.70M
Stochastic %K	59%
Beta	1.76
Analysts	Sell
Price Target	$5.67